Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

Medicus Pharma Ltd. MDCX shares surged to a high of $1.61 before falling during Thursday’s premarket session following the ...

Having successfully navigated the Humira patent cliff, AbbVie is poised for continued growth.

Now, it’s worth noting Stock Advisor’s total average return is 941 % — a market-crushing outperformance compared to 194% for ...

Aurinia Pharmaceutical stock is a "Hold" at current levels. Learn more about Lupkynis' momentum, AUPH's strong FY2025 cash flow, and analyst targets.

Now, it’s worth noting Stock Advisor’s total average return is 951 % — a market-crushing outperformance compared to 194% for ...

PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.

Royalty Pharma plc (NASDAQ:RPRX) is among the 11 Best Low Priced Growth Stocks to Buy Right Now. On February 12, Goldman ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...